Explore every hypothesis without being constrained by time, cost, or experimental capacity constrained by time, cost, or experimental capacity constrained by time, cost, or experimental
Read more

About Turbine

A lab without limits, built for biopharma. Turbine’s Virtual Lab digitizes biology, letting scientists run millions of virtual experiments at a scale no traditional lab can match. Instead of narrowing a hypothesis to fit resource constraints, teams use Turbine’s Virtual Assays, built on Turbine’s Virtual Cell model, to predict lab-like outputs, from cellular phenotypes to molecular states, across millions of conditions in parallel. Turbine doesn’t replace the wet lab. It makes every experiment count. Through a seamless Lab-in-the-Loop workflow, virtual findings become testable conditions, validated in-house, with a CRO partner, or through Turbine’s own lab, with results feeding back to sharpen every future prediction. The impact: decisions that once took 12 to 18 months now take as little as 2 months of in silico analysis, with over 50% wet lab experiments saved along the way.

Brand Asset Library

Please use these assets as provided or follow the included brand guidelines for any adaptations.

Logo pack

(RGB, CMYK, monochrome, transparent)

Download

Brand guidelines

(color palette, typography, logo usage)

Download

We have been featured in leading outlets covering the future of AI for Biology

Budapest-based Turbine has closed a $25 million Series B round, funding the next iteration of the decade-old startup’s long-running quest to build virtual cells.

AI promises to create medicines faster, more cheaply, and with greater precision. Despite attracting big sums and splashy headlines, AI-powered biotechs have yet to get a product over the finish line. Where is AI’s greatest impact so far?

AI promises to create medicines faster, more cheaply, and with greater precision. Despite attracting big sums and splashy headlines, AI-powered biotechs have yet to get a product over the finish line. Where is AI’s greatest impact so far?

Merck & Co's strategic investment fund was revealed as a co-lead investor.

Bayer representatives have written an article on Nature Research about digital healthcare. Reading the item, you can learn more about how AI / Machine Learning startups revolutionize the world of healthcare. Read it if you are interested in simulating drugs or accelerating clinical trials!